Skip to page content

Dutalys is a privately owned antibody technology company based in Vienna, Austria, and was established as a GmbH in April 2010. We are a growing and highly motivated team of people with diverse backgrounds, joined by a shared commitment to channel state-of-the-art empirical and computational approaches towards creating more effective antibody drugs.


Management

Roland Beckmann, PhD

  • Chief Scientific Officer and Co-founder, Dutalys
  • Previously responsible for European antibody engineering projects at Merck Serono (Geneva, Switzerland) and for development of bispecific antibodies at Domantis (Cambridge, UK)
  • For scientific queries, e-mail [email protected]

Kristian Jensen, PhD

  • VP Project Management and Business Development, Dutalys
  • Previously COO of Pieris AG (Munich, Germany)
  • Previously responsible for European antibody phage display projects at Merck Serono (Geneva, Switzerland)
  • For business queries, e-mail [email protected]

Mabel Mak, LLB

  • Legal Adviser and Co-founder, Dutalys
  • Corporate and litigation experience in Singapore, Geneva and Vienna
  • For legal and administrative queries, e-mail [email protected]